Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl


Preferences help
enabled [disable] Abstract
Number of results
2008 | 80 | 1 | 6-13

Article title

DNA Ploidy in the Treatment of Large Bowel Adenocarcinoma: A Follow up Study


Title variants

Languages of publication



The aim of the study was to look for unfavourable prognostic features in colorectal cancer patients after their surgical treatment as well as to evaluate the prognostic value of cellular ploidy and proliferative activity.Material and methods. A group of 71 colorectal cancer patients discharged from the hospital after surgical treatment in the years 1995-2000 was studied. The examined material was acquired from paraffin blocks of tumour segments. After histopathological verification, the tumour segments recovered from paraffin blocks were used for cytofluorometric analysis of cellular ploidy according to the Hedley method.Results. Diploid tumours were found in 45 of 71 (63.4%) colorectal cancer patients. No significant relationship between DNA ploidy and sex, age, complications, inherited susceptibility to a disease, tumour magnitude, grade of histological malignancy, or grade of clinical progression was observed. After colorectal cancer surgery, the probability of five- and ten-year survival was 44.4% and 37.1%, respectively, for the patients with diploid tumours (DI=1.0), and 38.5% and 9%, respectively, for the patients with aneuploid tumours (DI≠1.0). These differences were not statistically significant (p=0.120).Conclusions. 1. Classical clinicopathologic factors are still the best prognostic criteria for the evaluation of the future results of colorectal cancer patients' surgical treatment. 2. Determination of cellular ploidy and proliferative activity of colonic adenocarcinoma cannot increase the ability to predict prognosis based on surgical treatment.








Physical description


1 - 1 - 2008
18 - 2 - 2008


  • Department of General Surgery, Silesian Medical University, Katowice
  • Department of Surgery, Public Hospital, Zabrze
  • Department of Surgery, Public Hospital, Zabrze
  • Department of Neoplasm Pathology, Oncology Centre, Cracow
  • Department of General Surgery, Silesian Medical University, Katowice
  • Department of General Surgery, Silesian Medical University, Katowice


  • Chapman MA, Hardcastle JD, Armitage NC: Five-year prospective study of DNA tumor ploidy and colorectal cancer survival. Cancer 1995; 76: 383-97.[Crossref][PubMed]
  • Salud A, Porcel JM, Rainkundalia B et al.: Prognostic Significance of DNA Ploidy, S-Phase Fraction, and P-Glycoprotein Expression in Colorectal Cancer. J Surg Oncol 1999; 72: 167-74.[PubMed][Crossref]
  • Chen H, Sheen-Chen S, Lu C: DNA Index and S-phase Fraction in Curative Resection of Colorectal Adenocarcinoma: Analysis of Prognosis and Current Trends. World J Surg 2002; 26: 626-30.[PubMed][Crossref]
  • Hedley DW, Friedlander ML, Taylor IW et al.: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983; 31: 1333-35.[PubMed][Crossref]
  • Shankey TV, Rabinovitch PS, Bagwell B et al.: Guidelines for implementation of clinical DNA cytometry: Cytometry 1993; 14: 472-77.[Crossref][PubMed]
  • Hardy RG, Meltzer SJ, Jankowski. A: ABC of colorectal cancer. Molecular Basic for risk factors. BMJ 2000; 321: 886-89.
  • Bendardaf R, Lamlum H, Ristamaki R et al.: Response to Chemotherapy (Irinotecan plus 5-Fluorouracil) in Colorectal Carcinoma Can Be Predicted by Tumour DNA Content. Oncology 2004; 66: 46-52.[PubMed][Crossref]
  • Armitage NC, Robins RA, Ewans DF et al.: The influence of tumor cell DNA abnormalities on survival in colorectal cancer. Br J Surg 1985; 72: 828-30.[Crossref][PubMed]
  • Tonouchi H, Matsumoto H, Kinoshita T et al.: Prognostic Value of DNA Ploidy Patterns of Colorectal Adenocarcinoma: Univariate and Multivariate Analysis: Dig Surg 1998; 15: 687-92.
  • Bazan V, Migliavacca M, Zanna I et al.: DNA ploidy and S-phase fracion, but nott p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study. J Cancer Res Clin Oncol 2002; 128: 650-58.
  • Scott NA, Rainwater LM, Wiegand HS et al.: The relative prognostic value of flow cytometric DNA analysis and conventional clinicopathologic criteria in patients with operable rectal carcinoma. Dis Colon Rectum 1987; 30: 513-20.[PubMed][Crossref]
  • Kokal W, Sheibani K, Terz J et al.: Tumor DNA content in the prognosis of colorectal carcinoma. JAMA 1986; 255: 3123-27.
  • Takanishi DM Jr, Hart JH, Covarelli P et al.: Ploidy as a prognostic feature in colonic adenocarcinoma. Arch Surg 1996; 131: 587-92.
  • Melamed MR, Enker W, Banner P et al.: Flow cytometry of colorectal carcinoma with three year follow-up. Dis Colon Rectum 1986; 29: 184-86.[Crossref][PubMed]
  • Rognum TO, Lund E, Meling GI: Near diploid large bowel carcinomas have better five-year survival than aneuploid ones. Cancer 1991; 68: 1077-81.[PubMed][Crossref]
  • Enker WA, Kimmel M, Cibas ES et al.: DNA/RNA kontent and proliferative fractions of colorectal carcinoma: A five year prospective study relating flow cytometry to survival. J Natl Cancer Inst 1991; 83: 701-07.[Crossref]
  • Finan PJ, Quirke P, Dixon MF et al.: Is DNA aneuploidy a good prognostic mediator in patients with advanced colorectal cancer? Br J Cancer 1986; 54: 327-30.[Crossref]
  • Boettger TC, Potratz D, Stoeckle M et al.: Prognostic value of DNA analysis in colorectal carcinoma. Cancer 1993; 72: 3579-3587.[Crossref]
  • Olson RM, Perencevich NP, Malcolm AW et al.: Patterns of reccurence following curative resection of adenocarcinoma of the colon and rectum. Cancer 1980; 45: 2969-74.[Crossref]
  • Sasaki K, Kurose A, Uesugi N et al.: Intratumoral regional heterogeneity of DNA ploidy patterns in colorectal carcinomas. Anal Pathol 1995; 8: 323-30.
  • Dean PA, Vernava AM III: Flow cytometric analysis of DNA content in colorectal carcinoma. Dis Colon Rectum 1992; 35: 95-102.[Crossref]
  • Pinto AE, Chaves P, Fidalgo P et al.: FLOW cytometric DNA Ploidy and S-Phase Fraction Correlate with Histopathologic indicators of Tumor Behavior in Colorectal Carcinoma: Dis Colon Rectum 1997; 40: 411-19.[PubMed][Crossref]
  • Purdie CA, Piris J: Histopatological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma. Histopathology 2000; 36: 121-26.[Crossref]
  • Sugai T, Nakamura T, Habano W et al.: Usefulnes of proliferative activity, DNA ploidy pattern and p53 products as diagnostic adjuncts in colorectal adenomas and intramucosal carcinomas. Pathol-Int 1999; 49: 617-25.[Crossref]
  • Bauer KD, Bagwell CB, Giaretti W: Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer. Cytometry 1993; 14: 486-91.[PubMed][Crossref]
  • Zarbo RJ, Nakhleh RE, Brown RD et al.: Prognostic Significance of DNA Ploidy and Proliferation in 309 Colorectal Carcinomas as Determined by Two- Color Multiparametrik DNA Flow Cytometry. Cancer 1997; 79: 2073-86.
  • Lin JK, Chang SC, Yang SH et al.: Prognostic Value of DNA Ploidy Patterns of Colorectal Adenocarcinoma. Hepatogastroenterology 2003; 50: 1927-32.[PubMed]
  • Flyger HL, Larsen JK: Nielsen HJ et al.: DNA Ploidy in Colorectal Cancer, Heterogenity Within and Between Tumors and Relation to Survival: Cytometry (Communications in Clinical Cytometry) 1999; 38: 293-300.
  • Bosari S, Lee A, Wiley B et al.: Flow cytometric and image analyses of colorectal adenocarcinomas: a comparative study with clinical correlations. Am J Clin Pathol 1993; 99: 187-94.[PubMed]
  • Linden MD, Ma CK, Kubus J et al.: Ki-67 and proliferating cell nuclear antygen tumor proliferatives indices in DNA diploid colorectal adenocarcinomas correlation with histopatologic characteristics and cell cycle analysis with two-color DNA flow cytometry. Am J Clin Pathol 1993; 100: 206-12.

Document Type

Publication order reference


YADDA identifier

JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.